Trials / Completed
CompletedNCT01060488
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency
A Phase III, Multicentric, Open-label, Randomised, Comparative, Parallel Group Study of (GHRH + Arginine) Combination Test vs. Insulin Tolerance Test (ITT) in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Merck KGaA, Darmstadt, Germany · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to determine the specificity and sensitivity of the combined growth hormone releasing hormone (GHRH) + Arginine test in healthy volunteers, subjects with highly probable adult growth hormone deficiency (AGHD) and subjects who were probably free of AGHD.
Detailed description
The randomisation was carried out before the first test was performed. In order to be informed of the subject's randomisation group, the investigator phoned the access number given to him/her. The subject's allocation to a given randomisation arm was determined on the basis of a centralised randomisation (answering service), balanced per group of subjects with a minimisation on 2 criteria: age and BMI. This was a centralised randomisation using a Interactive Voice Response System (IVRS) which was balanced in each of the following 3 categories of subjects: * Category A = healthy volunteers, * Category B = subjects with a strong probability of deficit in GH, * Category C = subjects with a low probability of deficit in GH. In each of these 3 categories, the subjects underwent 3 tests whose sequences were determined by the following randomisation group: * Group 1: GHRH+Arg, GHRH+Arg, ITT or * Group 2: ITT, ITT, GHRH+Arg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GHRH+Arg, GHRH+Arg, ITT | GHRH+Arg repeatability test (2 tests) + comparison with one IT test |
| OTHER | ITT, ITT, GHRH+Arg. | IT repeatability test (2 tests) + comparison with one GHRH+Arg test |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2005-11-01
- First posted
- 2010-02-02
- Last updated
- 2014-08-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01060488. Inclusion in this directory is not an endorsement.